自动uARC计划在左侧乳腺癌同步加量调强放疗中的可行性研究OACSTPCD
Feasibility study of automated uARC planning for left breast cancer using simultaneous integrated boost intensity-modulated radiotherapy
目的 比较联影计划系统中左侧乳腺癌同步加量调强放疗自动优弧(uARC)计划和人工计划的剂量学和正常组织并发症概率(normal tissue complication probability,NTCP)差异,为临床应用提供依据.方法 回顾性收集2021年5月至2022年5月在河南省人民医院已完成同步加量调强放疗的左侧保乳术后女性乳腺癌患者21例.应用联影计划系统分别设计人工计划和自动uARC计划.评估两组计划靶区的平均剂量(mean dose,Dmean)、D2%、D98%、均匀性指数(homogeneity index,HI)、适形性指数(conformity index,CI)、危及器官剂量、计划时间和机器跳数的差异,计算并比较患侧肺、健侧肺及心脏的NTCP差异.结果 自动计划的靶区HI、CI、Dmean及V50均优于人工计划(均P<0.05),而人工计划的处方剂量为60 Gy的计划靶区(planning target volume,PTV)(PTV60)的D98%优于自动计划(P<0.05).自动计划患侧肺和心脏Dmean均优于人工计划[(9.35±0.47)Gy vs(9.61±0.37)Gy,(7.66±1.18)Gy vs(8.50±1.10)Gy,均 P<0.01].两组计划心脏 V30 和患侧肺 V30 比较,差异均无统计学意义(均P>0.05).自动计划和人工计划的计划时间分别为(25.00±2.30)min和(64.57±7.17)min(P<0.01).两组计划机器跳数比较,差异无统计学意义(P=0.207).自动计划肺和心脏的NTCP均低于人工计划(均P<0.01).结论 使用联影智能计划模块实现乳腺癌自动uARC计划具有一定可行性,并且能够提高靶区剂量覆盖,减少计划设计时间.
Objective To compare dosimetric parameters and normal tissue complication probability(NTCP)between automated uARC plan and manual plan in the simultaneous integrated boost(SIB)intensity-modulated radiotherapy(IMRT)of patients with left breast can-cer in order to investigate the feasibility of automated uARC planning.Methods Twenty-one patients with left breast cancer after breast conserving surgery who underwent SIB-IMRT in Henan Provincial People's Hospital from May 2021 to May 2022 were retrospectively se-lected.Automated uARC plan and manual plan were generated with the uRT-TPOIS treatment planning system(TPS)for each patient.The differences in the D2%,D98%,mean dose(Dmean),homogeneity index(HI)and conformity index(CI)of targets,dosimetric parameters of organs at risk(OARs),planning time and monitor unit(MU)were compared between automated and manual plans.NTCP for the ipsilateral lung,contralateral lung and heart were also analyzed.Results The HI,CI,Dmean and V50 of automated plan were better than those of manual plan(all P<0.05).The manual plan had a higher D98%for planning target volume(PTV)with prescribed dose of 60 Gy(PTV60)than automated plan(P<0.05).The mean doses of ipsilateral lung and heart of the automated plan were better than those of the manual plan[(9.35±0.47)Gy vs(9.61±0.37)Gy,(7.66±1.18)Gy vs(8.50±1.10)Gy,both P<0.05].No significant differences were found in the V30 of ipsilat-eral lung and heart(both P>0.05).Automated plan had a significantly shorter planning time than manual plan[(25.00±2.30)min vs(64.57±7.17)min,P<0.01].There was no signifcant difference in MU between automated and manual plans(P=0.207).Lung NTCP and heart NTCP were lower in automated plan than those in manual plan(all P<0.01).Conclusions It is feasible to generate automated uARC plan with uRT-TPOIS TPS for breast cancer patients.Automated uARC plan improves the dose coverage of PTV and reduce the planning time compared with manual plan.
梁恒坡;陶金柱;李良;谢家存;韩倩;邓金慧;林逢春
河南省人民医院(郑州大学人民医院)肿瘤中心,河南郑州 450003
乳腺癌同步加量调强放疗自动计划剂量学正常组织并发症概率
breast cancersimultaneous integrated boostautomated planningdosimetrynormal tissue complication probability
《实用肿瘤杂志》 2024 (003)
252-257 / 6
河南省科技攻关计划项目(212102310693)
评论